These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26398824)

  • 21. ERCC1 and small cell lung cancer.
    Rossi G; Nannini N; Tiseo M
    J Thorac Oncol; 2010 Nov; 5(11):1876-7. PubMed ID: 20975385
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.
    Kővári B; Szász AM; Kulka J; Marušić Z; Šarčević B; Tiszlavicz L; Cserni G
    Pathobiology; 2015 Sep; 82(3-4):166-71. PubMed ID: 26330357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
    Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
    J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary adenosquamous carcinoma with mucoepidermoid carcinoma-like component with characteristic p63 staining pattern: either a novel subtype originating from bronchial epithelium or variant mucoepidermoid carcinoma.
    Yamatani C; Abe M; Shimoji M; Maniwa T; Takahashi S; Isaka M; Ohde Y; Watanabe R; Ito I; Kondo H; Nakajima T
    Lung Cancer; 2014 Apr; 84(1):45-50. PubMed ID: 24513264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
    Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
    Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in the accurate subclassification of non-small-cell lung carcinoma for targeted therapy: issues and prospects.
    Osmani L; Li QK
    Biomark Med; 2017 May; 11(5):405-407. PubMed ID: 28621614
    [No Abstract]   [Full Text] [Related]  

  • 30. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
    Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
    J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of EML4-ALK fusion gene as a biomarker in non-small cell lung cancer].
    Wang L; Wang YH; Liu CY; Han M; Zhang SP; Lai RS
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):788-90. PubMed ID: 22336170
    [No Abstract]   [Full Text] [Related]  

  • 32. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
    Huang SM; Lu KT; Wang YC
    Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMP3 expression in non-small cell lung cancer.
    Bellezza G; Cavaliere A; Sidoni A
    Hum Pathol; 2009 Aug; 40(8):1205-6. PubMed ID: 19427669
    [No Abstract]   [Full Text] [Related]  

  • 34. Excision repair cross-complementing-1 for small cell lung cancer.
    Kim YH; Ishii G; Ochiai A
    J Thorac Oncol; 2011 Mar; 6(3):652; author reply 652. PubMed ID: 21317752
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
    Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
    J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
    Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
    Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TTF-1, napsin A and CDX2 co-expression in metastatic rectal adenocarcinoma to the lung.
    Li W; Cohen MB
    Cytopathology; 2021 Jan; 32(1):146-148. PubMed ID: 32633432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.